Server is temporarily unavailable
Main category: breast cancer
Article date: 09 Sep 2011-2: 00 PDT window.fbAsyncInit = function() {FB.init({_appId:_'aa16a4bf93f23f07eb33109d5f1134d3',_status:_true,_cookie:_true,_xfbml:_true,_channelUrl:_'http://www.medicalnewstoday.com/scripts/facebooklike.html'});}; (function() {var s = document.createElement('script'); = true e.async; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e);}()); email to a friend printer friendly opinions

Whether chemotherapy is given before or after breast-conserving therapy (BCT) does not have to impact on long-term local-regional outcomes, suggesting treatment success is due more to biologic factors than chemotherapy timing, according to a study by researchers at the University of Texas MD Anderson Cancer Center.

Presented today at the 2011 Breast Cancer Symposium, the study also found that neoadjuvant chemotherapy (given before surgery), often shrinks breast cancer tumors, making them more likely to be treatable with BCT, or a lumpectomy to remove a portion of the breast followed by radiation.

"Even women who present with clinical stage 2 or 3 breast cancer may have good results with BCT after chemotherapy and not need a mastectomy," said Elizabeth Ann Mittendorf, m.d., assistant professor in the Department of surgical oncology and lead author of the study. "The molecular characteristics of the tumor and other factors have an impact on treatment success, but not the order in which chemotherapy and surgery are given."

The retrospective study of almost 3,000 women treated for breast cancer at MD Anderson from 1987 to 2005 so confirmed several prior studies showing BCT offers high rates of cancer control for certain patients.

Approaches have similar outcomes

Of the patients surveyed, 78 percent had surgery before chemotherapy and 22 percent received chemotherapy first. Overall, women with more cancers that had more adverse prognostic factors PWRs to be treated with chemotherapy first.

Five and 10-year local-regional recurrence-free survival rates were excellent for both groups: 97 percent and 94 percent respectively for those who had surgery before chemotherapy, 93 percent and 90 percent for patients who received chemotherapy first.

Mittendorf said that if adverse features, such as stage and grade of the cancer, age of the patient and tumor hormone expression, were factored in, survival rates were essentially the same for both groups of women.

Neoadjuvant chemotherapy resulted in complete pathologic response in 20 percent of patients and lowered cancer stage in almost half of patients who had stage 2 or 3 cancer before chemotherapy, increasing the likelihood that BCT may be effective for many women after chemotherapy.

Results carrying forward

"This study shows that women appropriately selected for BCT, even some women with stage 3 breast cancer, can have excellent rates of local-regional control," Mittendorf said. "The most important thing is putting all the factors together to determine who can most benefit from this approach."

The group plans to extend the study into MD Anderson patients treated after 2005.

"Since 2005, treatment techniques have improved, including the ability to add targeted therapies to chemotherapy," she said. "In the future we look at the effects of newer agents, and we anticipate the wants results will be even more favorable for women who received these treatments before surgery."

Source: University of Texas M. D. Anderson Cancer Center

Article adapted by medical news today from original press release.

Visit our breast cancer section for the latest news on this subject.

There are no references listed for this article. Please use one of the following formats to cite this article in your essay, paper or report:

APA
University of Texas M. D. Anderson Cancer Center (2011, September 9). Chemotherapy is as effective before breast cancer surgery as after. Medical news today. Retrieved September 9, 2011 from http://www.medicalnewstoday.com/releases/234129.php MLA
University of Texas M. D. Anderson Cancer Center. "Chemotherapy is as effective before breast cancer surgery as after". Medical news today, September 9, 2011. Web. 9 Sep, 2011.

Please note: If no author information is provided, the source is cited instead.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact our news editor

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send press any medical news or health news releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

View the original article here

Peliculas Online